Influenza Vaccinations Benefit Patients Hospitalized With Pneumonia
In-hospital influenza vaccination may lower costs and risk for readmission or death.
In-hospital influenza vaccination may lower costs and risk for readmission or death.
There is significant disparity in the ratios for postbronchodilator FEV1/FEV6 and FEV1/FVC %, and this disparity is very pronounced in women.
Although uptake was limited, prophylactic treatment with moxifloxacin was well-tolerated in individuals with evidence of latent tuberculosis who were in contact with patients with high-risk multidrug-resistant tuberculosis.
Patients admitted to the hospital for myocardial infarction with a known diagnosis of obstructive sleep apnea were found to have improved in-hospital mortality.
Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.
Patients with tobacco dependence and pulmonary embolism are likely to be readmitted to the hospital within 30 days of initial discharge due to pulmonary embolism.
Gefapixant has demonstrated efficacy in improving objective cough frequency and quality of life among individuals with chronic cough.
Combination therapy consisting of once-daily macitentan and tadalafil was associated with reductions in pulmonary vascular resistance in patients with pulmonary arterial hypertension.
Thirty-day readmission following hospitalization for pneumonia is common in patients with underlying comorbidities such as COPD, kidney and heart diseases, and dementia.
Patients with acute exacerbation of COPD and acute MI who received invasive ventilation with high-concentration oxygen therapy experienced significant improvements in outcomes compared with patients on moderate-concentration oxygen therapy.